← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Sep 9, 2023
Acquired by Grifols on Sep 17, 2021
Timeline
2000s
- Jan 1, 2007
Biotest Pharmaceuticals— Founded
2020s
- Sep 17, 2021
Grifols— Acquired By
Drugs by trial phase (15 distinct, 29 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Afibrinogenemia
- Arthritis
- Arthritis, Rheumatoid
- Blood Coagulation Disorders
- Carcinoma, Hepatocellular
- Critical Illness
- Hemostatic Disorders
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis, Viral, Human
- Immunologic Deficiency Syndromes
- Liver Cirrhosis
- Liver Diseases
- Lupus Erythematosus, Systemic
- Multiple Myeloma
- Multiple Organ Failure
- Muscular Diseases
- Neoplasms, Plasma Cell
- Peritonitis
- Pneumonia
- Polyneuropathies
- Psoriasis
- Purpura, Thrombocytopenic, Idiopathic
- Sepsis
- Thrombocytopenia
Recent trials (34)
- NCT05722938Lead sponsorPhase 3Sep 9, 2023
- NCT05531149Lead sponsorPhase 3Jan 10, 2023
- NCT05370976CollaboratorPhase 2Sep 13, 2022
- NCT05345990CollaboratorPhase 2Aug 15, 2022
- NCT05170269Lead sponsorPhase 3Nov 17, 2021
- NCT04576728Lead sponsorPhase 2Oct 6, 2020
- NCT03444324Lead sponsorPhase 3Feb 12, 2018
- NCT03334006CollaboratorPhase 2Nov 20, 2017
- NCT03164967Lead sponsorPhase 4Dec 29, 2016
- NCT02859909Lead sponsorPhase 3Nov 1, 2016
- NCT02810444Lead sponsorPhase 3Oct 1, 2016
- NCT02554019Lead sponsorPhase 2Aug 1, 2015
- NCT01999192Lead sponsorPhase 2Oct 1, 2013
- NCT01804829Lead sponsorPhase 3Jun 1, 2013
- NCT02065882Lead sponsorPhase 2/Phase 3Mar 1, 2013
Details
- Founded
- Boca Raton, FL, US Jan 1, 2007
- Last known activity
- Sep 9, 2023